AGRX11 Unitholders: What Changes for You Now?
The primary risk highlighted in our June 2026 analysis—the Agrosepac CRA in early maturity—has been resolved. The company sold one of the farms pledged as collateral, cleared the overdue payments, and even prepaid upcoming installments. As a result, the early maturity was suspended, the credit returned to performing status, and the next interest payment is scheduled for September 2026. Consequently, the rating moves back up from 5.0 to 5.5 (NEUTRAL). In practice: if you already hold it, keep it. At R$ 8.51, the fund trades at a P/BV of 0.82 (an ~18% discount) and yields an annualized dividend yield of ~17.4%. This is neither a time to sell in panic nor an obvious bargain—the remaining risks have names and surnames: Hinove and a declining Selic rate.
What the New Filing Revealed
AGRX11 is a paper-based Fiagro (a Brazilian agribusiness receivables fund): instead of buying farms directly, it acquires agribusiness credit rights (primarily CRAs, or agribusiness receivables certificates) and passes the interest on to unitholders. This explains the high dividend yield, but the flip side is credit risk. That exact risk dominated our previous analysis, when the report exposed R$ 50.3 million in overdue payments ranging from 31 to 90 days, with the Agrosepac CRA declared in early maturity.
The May 2026 management report brings the resolution of this central issue: the Agrosepac case has been resolved. And how it happened matters just as much as the outcome.
How Early Maturity Works—and Why the Resolution Validates the Thesis
When a borrower breaches a contract (falls behind on installments, breaks covenants), the fund manager can declare early maturity: instead of waiting for monthly payments, it demands the entire balance due immediately and proceeds to execute the collateral. This is a severe stage, but it is also the moment when you find out whether the hard collateral promised on paper is actually worth anything.
In the case of Agrosepac, it was. The company sold one of the farms pledged as collateral, used the proceeds to clear the overdue amounts, and even prepaid future installments. As a result, the early maturity was suspended, the CRA returned to performing status, and the next interest payment is scheduled for September 2026.
This is more than just positive news for a single asset. It is proof of concept for the real collateral thesis: AGRX11's CRAs feature fiduciary alienations of rural real estate with coverage well above the outstanding balance, and the question was always whether those assets would convert into cash when things got tight. With Agrosepac, they did—without going through a protracted judicial auction, through a negotiated resolution. Credit goes to the manager, Éxes Gestora de Recursos, for executing the collateral competently, following the same standard as the Valéria CRA (recovered in full in 2025).
The Remaining Risk: Hinove
With Agrosepac resolved, the primary credit watch item shifts to the Hinove CRA (specialty fertilizers), which represents 8.8% of net asset value—approximately R$ 16.3 million.
Hinove is operating under a covenant waiver. In other words, a covenant is a clause requiring the company to maintain healthy financial ratios. Hinove closed the period with a current liquidity ratio of 0.84x, below the contractual minimum of 1.20x—meaning it held less short-term cash than required to cover its immediate obligations. A waiver is a temporary forgiveness of this breach, approved by unitholders in a general meeting, to avoid automatically triggering early maturity.
There are two concrete mitigating factors. The first is its short duration (1.29 years): the instrument matures naturally in 2027, so even if the company remains squeezed, the exposure timeframe is limited. The second is the real estate collateral—following the same model as Agrosepac, which just proved its worth in practice. The risk is not trivial (it is the largest remaining credit exposure), but it is mapped out, short-term, and backed by collateral. It is a yellow light, not a red one.
It is also worth noting what does not change: the Agrogalaxy CRA has remained 99% provisioned since December 2025 (the company is undergoing judicial reorganization). This is already priced into the fund's net asset value—there are no new surprises expected from it, and the residual balance is immaterial.
High Cash and the First Reinvestment (Renato CPR)
A side effect of resolving credit issues is ending up with cash on hand. Following the Agrosepac payoff and amortizations, the fund parked R$ 31.0 million in BTG Yield DI—representing 16.7% of net asset value, well above its historical average of around 6%.
Cash sitting in DI yields a return, but it yields less than the portfolio's CRAs: it creates a return drag until it is reinvested in agribusiness credit. The good news is that the manager has already taken the first step: it structured the Renato CPR (rural product note)—paying CDI + 9%, totaling R$ 4.5 million, with a 2-year term and rural real estate collateral valued at 550% of the outstanding balance. This is an operation with an attractive carry and ample collateral coverage, exactly the profile the fund needs to recycle its idle cash. The work ahead is repeating this a few times more to bring cash levels back to normal and restore the portfolio's average yield.
Selic Pressure on Portfolio Carry
With roughly 85% of its portfolio indexed to CDI+, AGRX11 is directly sensitive to the Selic rate—and it is falling. The portfolio's average return declined from CDI + 5.5% (April 2026) to CDI + 5.1% (May 2026), and monthly interest accrual fell from R$ 2.28 million to R$ 2.09 million over the same period.
The mechanism is direct: less accrued interest means less fuel for the distribution. The current DPU stands at R$ 0.12 per unit per month (next payment on July 15, 2026, referring to June 2026 results), still supported by a reserve of R$ 0.26 per unit (~2 months of distributions). The structural trend—regardless of credit developments—points to mild pressure on payouts as long as the Selic rate remains on a downward trajectory. Recycling high cash balances into operations like the Renato CPR helps offset part of this squeeze.
Current Monitoring Points
| Item | % of NAV | Status |
|---|---|---|
| Agrogalaxy CRA (Provisioned) | ~1% | Full provision (99%) since Dec/25 — no new surprises |
| Hinove CRA | 8.8% | Covenant waiver (liquidity 0.84x vs 1.20x). Duration 1.29y, matures in 2027 |
| Declining Average Return | — | CDI+5.1% (May) vs CDI+5.5% (Apr); accrual fell to R$ 2.09 million/month |
| Elevated Cash (BTG Yield DI) | 16.7% | Return drag; Renato CPR was the 1st reinvestment |
| Top 10 Concentration | — | Cash 16.7% · Éxes Terras 10.3% · Orbi 10.0% · Celeste 9.4% · Hinove 8.8% |
| Secondary Liquidity | — | ~R$ 332 thousand/day; orders above R$ 100 thousand impact pricing |
| Agrosepac (Resolved) | 6.4% | Farm sold, overdue amounts cleared, performing. Interest in Sep/26 |
Where the Price Stands in All This
At R$ 8.51, AGRX11 trades at a P/BV of 0.82—an ~18% discount to its net asset value of R$ 10.38. Part of this discount reflects the market pricing in remaining credit risk (Hinove) and the Agrogalaxy provision already recognized. However, the manager's own carry table (May 2026 management report) shows that buying at R$ 8.50 embeds an implicit return of CDI + 13.81%, signaling that the discount compensates for a substantial portion of the remaining risks for buy-and-hold investors.
Within the universe of agribusiness Fiagros focused on CRAs, AGRX11 is a mid-sized fund that is more concentrated and less liquid than larger-scale peers like RZAG11. This is not inherently a flaw—it is the profile of a fund that focuses on proprietary agribusiness credit origination backed by robust real collateral. The resolution of the Agrosepac case reinforces that this strategy has enforceable backing; what remains is for time to show the same outcome for Hinove and for the manager to recycle idle cash into operations matching the standard of the Renato CPR.
Verdict: NEUTRAL — Rating 5.5/10 (was 5.0, HOLD). The rating rises by 0.5 points because the primary risk from our previous analysis—the Agrosepac early maturity—was resolved through collateral execution (farm sale), validating in practice the thesis that these CRAs feature real collateral convertible into cash. The concrete remaining risks are the Hinove CRA (8.8% of NAV, covenant waiver, but short duration maturing in 2027) and the structural pressure of a falling Selic rate on portfolio carry. The ~18% discount to NAV and an implicit carry of CDI + 13.81% compensate for a large share of these risks.
For current unitholders: hold—the outlook has improved since June. For prospective investors: consider a gradual entry, keeping remaining risks in mind (Hinove and Selic). This is neither an obvious bargain nor a trap—it is an honest NEUTRO.
